Accredited symposium: Advancing TK2d management
Advancing TK2d management: From natural history to clinical evidence and real-world opportunities
Patients with TK2 deficiency still experience a diagnostic odyssey.
Watch this EBAC-accredited symposium recording, delivered at the 19th International Congress on Neuromuscular Diseases (ICNMD 2026), to gain expert insights into thymidine kinase 2 deficiency (TK2d). Join our panel of experts – Yolanda Cámara (Spain), Cristina Domínguez González (Spain), and Caterina Garone (Italy) – as they discuss the pathophysiology of TK2d, patient characterization and disease management, and real-world case studies.
Hear about:
- Underlying TK2d pathophysiology
- TK2d presentation and management
- Diagnosing TK2d
- The real-world clinical trajectory of TK2d
To earn 1 CME credit, watch the full session and then complete the knowledge assessment and evaluation form.
Important note: If you are not logged into your Medthority account, please complete the full session without exiting your browser. If you exit before finishing, you’ll need to restart from the beginning. We recommend logging in to preserve your progress if you need to pause. Not a member yet? You can set up your free account in just a few minutes.
EBAC accredited (1 CME credit)
“The earlier treatment is started, the greater the benefit." Recorded at ICNMD 2026, this symposium features expert discussions on the clinical spectrum of TK2d deficiency, highlighting key considerations in diagnosis, disease progression, and management. View transcript.
To view this resource, please enable "Functional Cookies" using the cookie icon at the bottom left of your screen. Learn more about how we use cookies in our privacy policy.
Meet the experts
Caterina Garone, MD, PhD
Caterina Garone is Associate Professor of Medical Genetics at Alma Mater Studiorum, University of Bologna, Italy, and a pediatric neurologist at UOC Neuropsichiatria dell'Età Pediatrica, S. Orsola Hospital. Garone specializes in clinical and translational research on metabolic disorders, mitochondrial diseases, neuromuscular diseases, and human genetics, with a particular focus as a neurogeneticist.
Disclosures: Serves on an advisory board of UCB Pharma. Received funding from UCB Pharma for research projects relating to TK2d.
Yolanda Cámara, PhD
Yolanda Cámara is a Senior Researcher at Vall d’Hebron Institute of Research, Barcelona, Spain. Cámara specializes in neuromuscular and mitochondrial pathology, with her research focused on the molecular mechanisms underlying mitochondrial diseases and disorders of oxidative metabolism, spanning both basic and translational research.
Disclosures: No disclosures reported.
Cristina Domínguez González, MD, PhD
Cristina Domínguez González leads multidisciplinary clinical and research groups at the Hospital 12 de Octubre in Madrid, Spain. Domínguez González’s area of expertise lies in genetic myopathies, with a particular focus on those originating from metabolic and mitochondrial factors.
Disclosures: Consulting fees from Amicus Therapeutics, Exeltis, Italfarmaco, Modis Therapeutics, Pharmanext, Roche, Sarepta, Sanofi–Genzyme, UCB Pharma, and Zogenix. Research funding from Pretzel Therapeutics and UCB Pharma. Honoraria from Amicus Therapeutics, Roche, Sanofi–Genzyme, and UCB Pharma.
Developed by EPG Health. This content has been developed independently of the sponsor, UCB Biopharma SRL, which had no editorial input into the content. EPG Health received unrestricted educational funding from the sponsor in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education, and associated relevant content. This content is intended for healthcare professionals only.
This activity has been accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC®) for 1:00 hours of effective education time.
EBAC® holds an agreement on mutual recognition of substantive equivalency with the US Accreditation Council for CME (ACCME) and the Royal College of Physicians and Surgeons of Canada, respectively.
Through an agreement between the European Board for Accreditation of Continuing Education for Health Professionals (EBAC®) and the American Medical Association, physicians may convert EBAC® External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC® credit to AMA credit can be found on the AMA website. Other health care professionals may obtain from the AMA a certificate of having participated in an activity eligible for conversion of credit to AMA PRA Category 1 Credit™.
Through an agreement between the Royal College of Physicians and Surgeons of Canada and the European Board for Accreditation of Continuing Education for Health Professionals, Royal College MOC Section 1 credits are deemed to be substantively equivalent to EBAC CPD credits.
EBAC® is a member of the International Academy for CPD Accreditation (IACPDA), the World Federation for Medical Education (WFME) CPD Recognition Committee, and a partner member of the International Association of Medical Regulatory Authorities (IAMRA).